Introduction: Little is known about racial differences in inpatient outcomes following hospitalizations for myasthenia gravis (MG). In this study, we used a claims-based database to assess racial differences in outcomes in hospitalized myasthenics. Methods: The 2006–2014 National Inpatient Sample database was queried using the International Classification of Diseases 9th Edition diagnosis code (358.01) to identify adult patients (age >17 years) undergoing hospitalization for MG. Race was categorized into – white, black/African American (AA), Asian or Pacific Islander, Hispanic, Native American, and other. Complications assessed included urinary tract infections, acute renal failure, cardiac complications, systemic infection, deep venous thrombosis, and pulmonary embolism. Multivariate logistic regression analyses were used to assess whether race was associated with a difference in outcomes, after controlling for baseline demographics, hospital characteristics, and treatment factors. Results: A total of 56,189 patient admissions, using a weighted sample, underwent hospitalization for MG between 2006 and 2014. Black/AA patients had significantly higher odds of experiencing systemic infections (odds ratio [OR] 1.35 [95% confidence intervals [CI] 1.16–1.58]; p < 0.001), deep venous thrombosis (OR 2.11 [95% CI 1.36–3.27]; p = 0.001), and renal failure (OR 1.19 [95% CI 1.05–1.35]; p = 0.005). Black/AA patients were more likely to be intubated (OR 1.09 [95% CI 1.01–1.19]; p = 0.028) and receive noninvasive mechanical ventilation (OR 1.62 [95% CI 1.46–1.79]; p < 0.001), however, were less likely to receive intravenous immunoglobulin (OR 0.77 [95% CI 0.73–0.82]; p < 0.001) and plasmapheresis (OR 0.77 [95% CI 0.72–0.82]; p < 0.001). Black/AA and Hispanic patients had lower mortality (OR 0.74 [95% CI 0.59–0.94; p = 0.012]. Conclusions: Significant racial differences exist in both treatment utilization and inpatient outcomes for patients hospitalized for MG.

1.
Graham
GN
,
Jones
PG
,
Chan
PS
,
Arnold
SV
,
Krumholz
HM
,
Spertus
JA
.
Racial disparities in patient characteristics and survival after acute myocardial infarction
.
JAMA Netw Open
.
2018 Nov 2
;
1
(
7
):
e184240
. .
2.
Barbieri
JS
,
Shin
DB
,
Wang
S
,
Margolis
DJ
,
Takeshita
J
.
Association of race/ethnicity and sex with differences in health care use and treatment for acne
.
JAMA Dermatol
.
2020 Mar 1
;
156
(
3
):
312
9
. .
3.
Gu
T
,
Mack
JA
,
Salvatore
M
,
Prabhu Sankar
S
,
Valley
TS
,
Singh
K
,
Characteristics associated with racial/ethnic disparities in COVID-19 outcomes in an academic health care system
.
JAMA Netw Open
.
2020 Oct 1
;
3
(
10
):
e2025197
. .
4.
Ogedegbe
G
,
Ravenell
J
,
Adhikari
S
,
Butler
M
,
Cook
T
,
Francois
F
,
Assessment of racial/ethnic disparities in hospitalization and mortality in patients with COVID-19 in New York City
.
JAMA Netw Open
.
2020 Dec 1
;
3
(
12
):
e2026881
. .
5.
Simon
S
,
Ho
PM
.
Ethnic and racial disparities in acute myocardial infarction
.
Curr Cardiol Rep
.
2020 Jul 9
;
22
(
9
):
88
. .
6.
Best
MJ
,
McFarland
EG
,
Thakkar
SC
,
Srikumaran
U
.
Racial disparities in the use of surgical procedures in the US
.
JAMA Surg
.
2021 Mar 1
;
156
(
3
):
274
81
. .
7.
Landon
BE
,
Onnela
JP
,
Meneades
L
,
O’Malley
AJ
,
Keating
NL
.
Assessment of racial disparities in primary care physician specialty referrals
.
JAMA Netw Open
.
2021 Jan 4
;
4
(
1
):
e2029238
. .
8.
Bravata
DM
,
Wells
CK
,
Gulanski
B
,
Kernan
WN
,
Brass
LM
,
Long
J
,
Racial disparities in stroke risk factors: the impact of socioeconomic status.
Stroke
.
2005
;
36
(
7
):
1507
11
. .
9.
Howard
G
,
Cushman
M
,
Kissela
BM
,
Kleindorfer
DO
,
McClure
LA
,
Safford
MM
,
Traditional risk factors as the underlying cause of racial disparities in stroke
.
Stroke
.
2011
;
42
(
12
):
3369
75
. .
10.
Hsia
AW
,
Edwards
DF
,
Morgenstern
LB
,
Wing
JJ
,
Brown
NC
,
Coles
R
,
Racial disparities in tissue plasminogen activator treatment rate for stroke: a population-based study.
Stroke
.
2011
;
42
(
8
):
2217
21
. .
11.
Gardener
H
,
Sacco
RL
,
Rundek
T
,
Battistella
V
,
Cheung
YK
,
Elkind
MSV
.
Race and ethnic disparities in stroke incidence in the Northern Manhattan Study
.
Stroke
.
2020
;
51
(
4
):
1064
9
. .
12.
Kamin Mukaz
D
,
Zakai
NA
,
Cruz-Flores
S
,
McCullough
LD
,
Cushman
M
.
Identifying genetic and biological determinants of race-ethnic disparities in stroke in the United States
.
Stroke
.
2020
;
51
(
11
):
3417
24
. .
13.
Ropper
AH
,
Gress
DR
,
Diringer
MN
,
Green
DM
,
Mayer
SA
,
Bleck
TP
.
Neurological and neurosurgical intensive care
. 4th ed.
Philadelphia
:
Lippincott Williams & Wilkins
;
2004
. p.
39
.
14.
O'Riordan
JI
,
Miller
DH
,
Mottershead
JP
,
Hirsch
NP
,
Howard
RS
.
The management and outcome of patients with myasthenia gravis treated acutely in a neurological intensive care unit
.
Eur J Neurol
.
1998 Mar
;
5
(
2
):
137
42
. .
15.
Rabinstein
AA
,
Mueller-Kronast
N
.
Risk of extubation failure in patients with myasthenic crisis
.
Neurocrit Care
.
2005
;
3
(
3
):
213
5
. .
16.
HCUP National Inpatient Sample (NIS)
.
Healthcare Cost and Utilization Project (HCUP)
.
Rockville, MD
:
Agency for Healthcare Research and Quality
;
2011
.
17.
Nationwide Inpatient Sample (NIS)
.
Healthcare Cost and Utilization Project (HCUP)
.
Rockville, MD
:
Agency for Healthcare Research and Quality
;
2012
.
18.
Alshekhlee
A
,
Miles
JD
,
Katirji
B
,
Preston
DC
,
Kaminski
HJ
.
Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals
.
Neurology
.
2009 May 5
;
72
(
18
):
1548
54
. .
19.
Desai
R
,
Abbas
SA
,
Fong
HK
,
Lodhi
MU
,
Doshi
R
,
Savani
S
,
Burden and impact of takotsubo syndrome in myasthenic crisis: a national inpatient perspective on the under-recognized but potentially fatal association
.
Int J Cardiol
.
2020 Jan 15
;
299
:
63
6
. .
20.
Elixhauser
A
,
Steiner
C
,
Harris
DR
,
Coffey
RM
.
Comorbidity measures for use with administrative data
.
Med Care
.
1998 Jan
;
36
(
1
):
8
27
. .
21.
Pool
LR
,
Ning
H
,
Lloyd-Jones
DM
,
Allen
NB
.
Trends in racial/ethnic disparities in cardiovascular health among US adults from 1999–2012
.
J Am Heart Assoc
.
2017 Sep 22
;
6
(
9
):
e006027
. .
22.
Saadi
A
,
Himmelstein
DU
,
Woolhandler
S
,
Mejia
NI
.
Racial disparities in neurologic health care access and utilization in the United States
.
Neurology
.
2017 Jun 13
;
88
(
24
):
2268
75
. .
23.
Zimmerman
FJ
,
Anderson
NW
.
Trends in health equity in the United States by race/ethnicity, sex, and income, 1993–2017
.
JAMA Netw Open
.
2019 Jun 5
;
2
(
6
):
e196386
. .
24.
Rangrass
G
,
Ghaferi
AA
,
Dimick
JB
.
Explaining racial disparities in outcomes after cardiac surgery: the role of hospital quality
.
JAMA Surg
.
2014 Mar
;
149
(
3
):
223
7
. .
25.
Singh
JA
,
Lu
X
,
Rosenthal
GE
,
Ibrahim
S
,
Cram
P
.
Racial disparities in knee and hip total joint arthroplasty: an 18-year analysis of national Medicare data
.
Ann Rheum Dis
.
2014 Dec
;
73
(
12
):
2107
15
. .
26.
Hall
EC
,
Hashmi
ZG
,
Zafar
SN
,
Zogg
CK
,
Cornwell
EE
 3rd
,
Haider
AH
.
Racial/ethnic disparities in emergency general surgery: explained by hospital-level characteristics?
Am J Surg
.
2015 Apr
;
209
(
4
):
604
9
. .
27.
Zogg
CK
,
Jiang
W
,
Chaudhary
MA
,
Scott
JW
,
Shah
AA
,
Lipsitz
SR
,
Racial disparities in emergency general surgery: do differences in outcomes persist among universally insured military patients?
J Trauma Acute Care Surg
.
2016 May
;
80
(
5
):
764
75
; discussion 775–7. .
28.
Sacco
RL
.
Stroke disparities: from observations to actions: inaugural Edward J. Kenton lecture 2020.
Stroke
.
2020
;
51
(
11
):
3392
405
. .
29.
Amezcua
L
,
Rivera
VM
,
Vazquez
TC
,
Baezconde-Garbanati
L
,
Langer-Gould
A
.
Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review
.
JAMA Neurol
.
2021 Oct
;
78
(
12
):
1515
. .
30.
Qiao
WP
,
Powell
ES
,
Witte
MP
,
Zelder
MR
.
Relationship between racial disparities in ED wait times and illness severity
.
Am J Emerg Med
.
2016 Jan
;
34
(
1
):
10
5
. .
31.
Zhang
X
,
Carabello
M
,
Hill
T
,
Bell
SA
,
Stephenson
R
,
Mahajan
P
.
Trends of racial/ethnic differences in emergency department care outcomes among adults in the United States from 2005 to 2016
.
Front Med
.
2020
;
7
:
300
. .
32.
Wendell
LC
,
Levine
JM
.
Myasthenic crisis
.
Neurohospitalist
.
2011 Jan
;
1
(
1
):
16
22
. .
33.
Mandawat
A
,
Kaminski
HJ
,
Cutter
G
,
Katirji
B
,
Alshekhlee
A
.
Comparative analysis of therapeutic options used for myasthenia gravis
.
Ann Neurol
.
2010 Dec
;
68
(
6
):
797
805
. .
34.
Moore
JX
,
Donnelly
JP
,
Griffin
R
,
Safford
MM
,
Howard
G
,
Baddley
J
,
Black-white racial disparities in sepsis: a prospective analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort
.
Crit Care
.
2015 Jul 10
;
19
:
279
. .
35.
Jones
JM
,
Fingar
KR
,
Miller
MA
,
Coffey
R
,
Barrett
M
,
Flottemesch
T
,
Racial disparities in sepsis-related in-hospital mortality: using a broad case capture method and multivariate controls for clinical and hospital variables, 2004–2013
.
Crit Care Med
.
2017 Dec
;
45
(
12
):
e1209
e1217
. .
36.
Burke
JF
,
Feng
C
,
Skolarus
LE
.
Divergent poststroke outcomes for black patients: lower mortality, but greater disability
.
Neurology
.
2019 Oct 29
;
93
(
18
):
e1664
e1674
. .
37.
Johnson
KS
,
Kuchibhatla
M
,
Tanis
D
,
Tulsky
JA
.
Racial differences in hospice revocation to pursue aggressive care
.
Arch Intern Med
.
2008 Jan 28
;
168
(
2
):
218
24
. .
38.
Oh
SJ
,
Morgan
MB
,
Lu
L
,
Hatanaka
Y
,
Hemmi
S
,
Young
A
,
Racial differences in myasthenia gravis in Alabama
.
Muscle Nerve
.
2009 Mar
;
39
(
3
):
328
32
. .
39.
Abukhalil
F
,
Mehta
B
,
Saito
E
,
Mehta
S
,
McMurtray
A
.
Gender and ethnicity based differences in clinical and laboratory features of myasthenia gravis
.
Autoimmune Dis
.
2015
;
2015
:
197893
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.